{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:38:09Z","timestamp":1790534289790,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12969-018-0278-1","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T11:34:59Z","timestamp":1537961699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C \u03b4"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3734-3173","authenticated-orcid":false,"given":"Linda","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthana","family":"Al-Obaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Sebire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iek Leng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Eleftheriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"278_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coi.2017.10.008","volume":"49","author":"P Costa-Reis","year":"2017","unstructured":"Costa-Reis P, Sullivan KE. Monogenic lupus: it's all new! Curr Opin Immunol. 2017;49:87\u201395.","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"278_CR2","doi-asserted-by":"publisher","first-page":"e0181874","DOI":"10.1371\/journal.pone.0181874","volume":"12","author":"E Omoyinmi","year":"2017","unstructured":"Omoyinmi E, Standing A, Keylock A, Price-Kuehne F, Melo Gomes S, Rowczenio D, et al. Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis. PLoS One. 2017;12(7):e0181874.","journal-title":"PLoS One"},{"issue":"1","key":"278_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1546-0096-10-21","volume":"10","author":"A Belot","year":"2012","unstructured":"Belot A, Cimaz R. Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis. Pediatr Rheumatol Online J. 2012;10(1):21.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"278_CR4","doi-asserted-by":"publisher","first-page":"e20160781","DOI":"10.1542\/peds.2016-0781","volume":"139","author":"Sira Nanthapisal","year":"2016","unstructured":"Nanthapisal S, Omoyinmi E, Murphy C, Standing A, Eisenhut M, Eleftheriou D, Brogan PA. Early-Onset Juvenile SLE Associated With a Novel Mutation in Protein Kinase C \u03b4. Pediatrics. 2017;139(1). Article E20160781.","journal-title":"Pediatrics"},{"issue":"6883","key":"278_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/416865a","volume":"416","author":"M Akitomo","year":"2002","unstructured":"Akitomo M, Keiko N, Hiroyuki I, Sachiko H, Yi J, Masaaki A, et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase C\u03b4. Nature. 2002;416(6883):865.","journal-title":"Nature"},{"issue":"21","key":"278_CR6","doi-asserted-by":"publisher","first-page":"10159","DOI":"10.1073\/pnas.89.21.10159","volume":"89","author":"T Watanabe","year":"1992","unstructured":"Watanabe T, Ono Y, Taniyama Y, Hazama K, Igarashi K, Ogita K, et al. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies. Proc Natl Acad Sci U S A. 1992;89(21):10159\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 5","key":"278_CR7","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1042\/BST0351001","volume":"35","author":"ME Reyland","year":"2007","unstructured":"Reyland ME. Protein kinase Cdelta and apoptosis. Biochem Soc Trans. 2007;35(Pt 5):1001\u20134.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"278_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/sj.cdd.4400929","volume":"9","author":"MF Denning","year":"2002","unstructured":"Denning MF, Wang Y, Tibudan S, Alkan S, Nickoloff BJ, Qin JZ. Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C. Cell Death Differ. 2002;9(1):40\u201352.","journal-title":"Cell Death Differ"},{"issue":"25","key":"278_CR9","doi-asserted-by":"publisher","first-page":"17731","DOI":"10.1074\/jbc.M801727200","volume":"283","author":"SL Lomonaco","year":"2008","unstructured":"Lomonaco SL, Kahana S, Blass M, Brody Y, Okhrimenko H, Xiang C, et al. Phosphorylation of protein kinase Cdelta on distinct tyrosine residues induces sustained activation of Erk1\/2 via down-regulation of MKP-1: role in the apoptotic effect of etoposide. J Biol Chem. 2008;283(25):17731\u20139.","journal-title":"J Biol Chem"},{"issue":"6883","key":"278_CR10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/416865a","volume":"416","author":"A Miyamoto","year":"2002","unstructured":"Miyamoto A, Nakayama K, Imaki H, Hirose S, Jiang Y, Abe M, et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature. 2002;416(6883):865\u20139.","journal-title":"Nature"},{"issue":"8","key":"278_CR11","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/art.38008","volume":"65","author":"A Belot","year":"2013","unstructured":"Belot A, Kasher PR, Trotter EW, Foray AP, Debaud AL, Rice GI, et al. Protein kinase c\u03b4 deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum. 2013;65(8):2161\u201371.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"278_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrd3100","volume":"9","author":"MJ Keating","year":"2010","unstructured":"Keating MJ, Dritselis A, Yasothan U, Kirkpatrick P. Ofatumumab. Nat Rev Drug Discov. 2010;9(2):101\u20132.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"278_CR13","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1182\/blood-2004-01-0039","volume":"104","author":"JL Teeling","year":"2004","unstructured":"Teeling JL, French RR, Cragg MS, van den Brakel J, Pluyter M, Huang H, et al. Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas. Blood. 2004;104(6):1793\u2013800.","journal-title":"Blood"},{"issue":"7","key":"278_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1212\/WNL.0000000000000125","volume":"82","author":"PS Sorensen","year":"2014","unstructured":"Sorensen PS, Lisby S, Grove R, Derosier F, Shackelford S, Havrdova E, et al. Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study. Neurology. 2014;82(7):573\u201381.","journal-title":"Neurology"},{"issue":"12","key":"278_CR15","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.1182\/blood-2007-10-117671","volume":"111","author":"A Hagenbeek","year":"2008","unstructured":"Hagenbeek A, Gadeberg O, Johnson P, Pedersen LM, Walewski J, Hellmann A, et al. First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1\/2 trial. Blood. 2008;111(12):5486\u201395.","journal-title":"Blood"},{"issue":"3","key":"278_CR16","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1182\/blood-2007-09-111781","volume":"111","author":"B Coiffier","year":"2008","unstructured":"Coiffier B, Lepretre S, Pedersen LM, Gadeberg O, Fredriksen H, van Oers MH, et al. Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study. Blood. 2008;111(3):1094\u2013100.","journal-title":"Blood"},{"issue":"12","key":"278_CR17","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1136\/ard.2011.151522","volume":"70","author":"PC Taylor","year":"2011","unstructured":"Taylor PC, Quattrocchi E, Mallett S, Kurrasch R, Petersen J, Chang DJ. Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial. Ann Rheum Dis. 2011;70(12):2119\u201325.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"278_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/rheumatology\/kex395","volume":"57","author":"EM McCarthy","year":"2018","unstructured":"McCarthy EM, Sutton E, Nesbit S, White J, Parker B, Jayne D, et al. Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles lupus assessment group biologics register. Rheumatology (Oxford). 2018;57(3):470\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"278_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/rheumatology\/keu475","volume":"54","author":"CC Thornton","year":"2015","unstructured":"Thornton CC, Ambrose N, Ioannou Y. Ofatumumab: a novel treatment for severe systemic lupus erythematosus. Rheumatology (Oxford). 2015;54(3):559\u201360.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"278_CR20","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1093\/rheumatology\/kew267","volume":"55","author":"T Karageorgas","year":"2016","unstructured":"Karageorgas T, Zomas A, Kazakou P, Katsimbri P, Mantzourani M, Boumpas D. Successful treatment of life-threatening autoimmune haemolytic anaemia with ofatumumab in a patient with systemic lupus erythematosus. Rheumatology (Oxford). 2016;55(11):2085\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"278_CR21","doi-asserted-by":"crossref","unstructured":"Bonanni A, Rossi R, Murtas C, Ghiggeri GM. Low-dose ofatumumab for rituximab-resistant nephrotic syndrome. BMJ Case Rep. 2015;2015.","DOI":"10.1136\/bcr-2015-210208"},{"issue":"1","key":"278_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00467-016-3498-y","volume":"32","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli M, Colucci M, Bonanni A, Verzani M, Serafinelli J, Emma F, et al. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab. Pediatr Nephrol. 2017;32(1):181\u20134.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"278_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/0961203312470729","volume":"22","author":"B Alchi","year":"2013","unstructured":"Alchi B, Jayne D, Labopin M, Demin A, Sergeevicheva V, Alexander T, et al. Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry. Lupus. 2013;22(3):245\u201353.","journal-title":"Lupus"},{"issue":"3","key":"278_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1191\/0961203304lu525oa","volume":"13","author":"D Jayne","year":"2004","unstructured":"Jayne D, Passweg J, Marmont A, Farge D, Zhao X, Arnold R, et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus. 2004;13(3):168\u201376.","journal-title":"Lupus"},{"issue":"8","key":"278_CR25","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677\u201386.","journal-title":"Arthritis Rheum"},{"issue":"16","key":"278_CR26","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1182\/blood-2012-12-469544","volume":"121","author":"HS Kuehn","year":"2013","unstructured":"Kuehn HS, Niemela JE, Rangel-Santos A, Zhang M, Pittaluga S, Stoddard JL, et al. Loss-of-function of the protein kinase C \u03b4 (PKC\u03b4) causes a B-cell lymphoproliferative syndrome in humans. Blood. 2013;121(16):3117\u201325.","journal-title":"Blood"},{"issue":"2","key":"278_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/0961203306075382","volume":"16","author":"J Andre","year":"2007","unstructured":"Andre J, Cimaz R, Ranchin B, Galambrun C, Bertrand Y, Bouvier R, et al. Overexpression of the antiapoptotic gene Bfl-1 in B cells from patients with familial systemic lupus erythematosus. Lupus. 2007;16(2):95\u2013100.","journal-title":"Lupus"},{"issue":"16","key":"278_CR28","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1182\/blood-2012-10-460741","volume":"121","author":"E Salzer","year":"2013","unstructured":"Salzer E, Santos-Valente E, Klaver S, Ban SA, Emminger W, Prengemann NK, et al. B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C \u03b4. Blood. 2013;121(16):3112\u20136.","journal-title":"Blood"},{"issue":"6","key":"278_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10875-015-0178-9","volume":"35","author":"A Kiykim","year":"2015","unstructured":"Kiykim A, Ogulur I, Baris S, Salzer E, Karakoc-Aydiner E, Ozen AO, et al. Potentially beneficial effect of hydroxychloroquine in a patient with a novel mutation in protein kinase C\u03b4 deficiency. J Clin Immunol. 2015;35(6):523\u20136.","journal-title":"J Clin Immunol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0278-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-018-0278-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0278-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T19:12:08Z","timestamp":1569438728000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-018-0278-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["278"],"URL":"https:\/\/doi.org\/10.1186\/s12969-018-0278-1","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,26]]},"assertion":[{"value":"19 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed with ethical approval and consent from all included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DE has institutional grants from Pfizer and Lilly. PB received consultancy fees from Roche and SOBI, institutional grants from Roche, SOBI and Novartis, and speaker fees from UCB. The other authors have declared no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"61"}}